4013

COM:HMG

Dr. Sulaiman Al Habib Medical Group

Stock

Last Close

271.20

21/11 12:16

Market Cap

97.93B

Beta: -

Volume Today

161.35K

Avg: -

Overview Analysis Metrics Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	903.27M -	1.13B 24.86%	1.50B 33.12%	1.80B 19.67%	2.05B 13.88%
depreciation and amortization	255.92M -	317.82M 24.19%	314.79M 0.95%	309.22M 1.77%	312.68M 1.12%
deferred income tax
stock based compensation
change in working capital	-204.96M -	549.94M 368.32%	151.29M 72.49%	523.43M 245.97%	382.19M 26.98%
accounts receivables	-322.56M -	530.06M 264.33%	-200.62M 137.85%	-40.29M 79.92%	-202.43M 402.44%
inventory	-28.16M -	-83.97M 198.19%	-26.98M 67.87%	-83.50M 209.52%	-58.18M 30.32%
accounts payables	139.10M -	-27.81M 119.99%	176.97M 736.43%	156.19M 11.74%	326.08M 108.77%
other working capital	6.66M -	131.65M 1,876.40%	201.92M 53.37%	491.03M 143.18%	316.73M 35.50%
other non cash items	104.86M -	182.44M 73.99%	215.36M 18.05%	214.37M 0.46%	452.10M 110.89%
net cash provided by operating activities	1.06B -	2.18B 105.65%	2.18B 0.22%	2.84B 30.28%	3.19B 12.28%
investments in property plant and equipment	-732.89M -	-757.69M 3.38%	-1.25B 65.44%	-1.51B 20.73%	-3.50B 131.07%
acquisitions net	-2.77M -			-126.04M -	-256K 99.80%
purchases of investments	-2.77M -			-300M -	-2.55M 99.15%
sales maturities of investments	2.77M -			30M -
other investing activites	5M -	2M 60%	6M 200%	-30M 600%	256K 100.85%
net cash used for investing activites	-730.66M -	-755.69M 3.43%	-1.25B 65.08%	-1.94B 55.46%	-3.50B 80.44%
debt repayment	-471.17M -	-349.71M 25.78%	-396.00M 13.24%	-432.33M 9.17%	-1.70B 293.33%
common stock issued
common stock repurchased
dividends paid	-903.36M -	-525M 41.88%	-945M 80%	-1.14B 20.37%	-1.44B 26.15%
other financing activites	873.65M -	595.00M 31.89%	710.30M 19.38%	768.71M 8.22%	3.32B 331.29%
net cash used provided by financing activities	-500.89M -	-279.71M 44.16%	-630.70M 125.49%	-801.12M 27.02%	179.86M 122.45%
effect of forex changes on cash
net change in cash	-172.46M -	1.14B 762.54%	304.57M 73.34%	103.16M 66.13%	-126.61M 222.73%
cash at beginning of period	1.37B -	1.20B 12.60%	2.34B 95.48%	2.64B 13.02%	2.75B 3.90%
cash at end of period	1.20B -	2.34B 95.48%	2.64B 13.02%	2.75B 3.90%	2.62B 4.61%
operating cash flow	1.06B -	2.18B 105.65%	2.18B 0.22%	2.84B 30.28%	3.19B 12.28%
capital expenditure	-732.89M -	-757.69M 3.38%	-1.25B 65.44%	-1.51B 20.73%	-3.50B 131.07%
free cash flow	326.20M -	1.42B 335.41%	929.27M 34.57%	1.33B 43.16%	-303.91M 122.85%

All numbers in (except ratios and percentages)